Charles River Laboratories CRL Payments for Restructuring
Payments for Restructuring at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRestructuring.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's payments for restructuring.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's payments for restructuring?
- Charles River Laboratories (CRL) reported payments for restructuring of $17.3M in Q1 2026.
- How has Charles River Laboratories's payments for restructuring changed year-over-year?
- Charles River Laboratories's payments for restructuring increased by 20.8% year-over-year, from $14.32M to $17.3M.
- What is the long-term trend for Charles River Laboratories's payments for restructuring?
- Over 2 years (2023 to 2025), Charles River Laboratories's payments for restructuring has grown at a 146.2% compound annual growth rate (CAGR), from $9.64M to $58.47M.
- What does payments for restructuring mean?
- Cash spent on restructuring activities during the period.
- How do you interpret payments for restructuring?
- High cash outflows indicate active execution of restructuring plans, impacting short-term liquidity.
- How does payments for restructuring compare across companies?
- Used by analysts to reconcile cash flow statements with restructuring charges reported in earnings.